ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Implant Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6X5138
Home | Market Reports | Health| Health Foundations & Medical Research
Global Drug Eluting Implant Market Insights Forecast to 2028
BUY CHAPTERS

Global Drug Eluting Implant Market Research Report 2025

Code: QYRE-Auto-6X5138
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boston Scientific
Medtronic Inc
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik AG
Shandong JW Medical
Sino Medical
Beijing AMSINO

Drug Eluting Implant Market Size

The global market for Drug Eluting Implant was valued at US$ 7567 million in the year 2024 and is projected to reach a revised size of US$ 11760 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Drug Eluting Implant Market

Drug Eluting Implant Market

Drug eluting implants encompass a wide range of bioactive implants that can be placed in or near a tissue to provide a controlled, sustained or on demand release of drug while overcoming barriers associated with traditional oral and intravenous drug administration, such as limited bioavailability, metabolism, and toxicity.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Implant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Implant.
The Drug Eluting Implant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Eluting Implant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Implant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Eluting Implant Market Report

Report Metric Details
Report Name Drug Eluting Implant Market
Accounted market size in year US$ 7567 million
Forecasted market size in 2031 US$ 11760 million
CAGR 6.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, AlviMedica Medical Technologies, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Eluting Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Eluting Implant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Drug Eluting Implant Market growing?

Ans: The Drug Eluting Implant Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Drug Eluting Implant Market size in 2031?

Ans: The Drug Eluting Implant Market size in 2031 will be US$ 11760 million.

Who are the main players in the Drug Eluting Implant Market report?

Ans: The main players in the Drug Eluting Implant Market are Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, AlviMedica Medical Technologies, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO

What are the Application segmentation covered in the Drug Eluting Implant Market report?

Ans: The Applications covered in the Drug Eluting Implant Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Drug Eluting Implant Market report?

Ans: The Types covered in the Drug Eluting Implant Market report are Rapamycin Eluting Implant, Paclitaxel Eluting Implant, Everolimus Eluting Implant, Others

Recommended Reports

Drug Delivery Devices

Cardiovascular Therapies

Advanced Medical Treatments

1 Drug Eluting Implant Market Overview
1.1 Product Definition
1.2 Drug Eluting Implant by Type
1.2.1 Global Drug Eluting Implant Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rapamycin Eluting Implant
1.2.3 Paclitaxel Eluting Implant
1.2.4 Everolimus Eluting Implant
1.2.5 Others
1.3 Drug Eluting Implant by Application
1.3.1 Global Drug Eluting Implant Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Drug Eluting Implant Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Implant Revenue 2020-2031
1.4.2 Global Drug Eluting Implant Sales 2020-2031
1.4.3 Global Drug Eluting Implant Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Eluting Implant Market Competition by Manufacturers
2.1 Global Drug Eluting Implant Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Eluting Implant Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Eluting Implant Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Eluting Implant, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Implant, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Implant, Product Type & Application
2.7 Global Key Manufacturers of Drug Eluting Implant, Date of Enter into This Industry
2.8 Global Drug Eluting Implant Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Implant Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Eluting Implant Players Market Share by Revenue
2.8.3 Global Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Implant Market Scenario by Region
3.1 Global Drug Eluting Implant Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Eluting Implant Sales by Region: 2020-2031
3.2.1 Global Drug Eluting Implant Sales by Region: 2020-2025
3.2.2 Global Drug Eluting Implant Sales by Region: 2026-2031
3.3 Global Drug Eluting Implant Revenue by Region: 2020-2031
3.3.1 Global Drug Eluting Implant Revenue by Region: 2020-2025
3.3.2 Global Drug Eluting Implant Revenue by Region: 2026-2031
3.4 North America Drug Eluting Implant Market Facts & Figures by Country
3.4.1 North America Drug Eluting Implant Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Eluting Implant Sales by Country (2020-2031)
3.4.3 North America Drug Eluting Implant Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Implant Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Implant Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Eluting Implant Sales by Country (2020-2031)
3.5.3 Europe Drug Eluting Implant Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Implant Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Implant Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Eluting Implant Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Eluting Implant Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Implant Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Implant Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Eluting Implant Sales by Country (2020-2031)
3.7.3 Latin America Drug Eluting Implant Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Implant Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Implant Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Eluting Implant Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Eluting Implant Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Implant Sales by Type (2020-2031)
4.1.1 Global Drug Eluting Implant Sales by Type (2020-2025)
4.1.2 Global Drug Eluting Implant Sales by Type (2026-2031)
4.1.3 Global Drug Eluting Implant Sales Market Share by Type (2020-2031)
4.2 Global Drug Eluting Implant Revenue by Type (2020-2031)
4.2.1 Global Drug Eluting Implant Revenue by Type (2020-2025)
4.2.2 Global Drug Eluting Implant Revenue by Type (2026-2031)
4.2.3 Global Drug Eluting Implant Revenue Market Share by Type (2020-2031)
4.3 Global Drug Eluting Implant Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Eluting Implant Sales by Application (2020-2031)
5.1.1 Global Drug Eluting Implant Sales by Application (2020-2025)
5.1.2 Global Drug Eluting Implant Sales by Application (2026-2031)
5.1.3 Global Drug Eluting Implant Sales Market Share by Application (2020-2031)
5.2 Global Drug Eluting Implant Revenue by Application (2020-2031)
5.2.1 Global Drug Eluting Implant Revenue by Application (2020-2025)
5.2.2 Global Drug Eluting Implant Revenue by Application (2026-2031)
5.2.3 Global Drug Eluting Implant Revenue Market Share by Application (2020-2031)
5.3 Global Drug Eluting Implant Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific Drug Eluting Implant Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Drug Eluting Implant Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Drug Eluting Implant Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Company Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lepu Medical Drug Eluting Implant Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 B. Braun Melsungen
6.5.1 B. Braun Melsungen Company Information
6.5.2 B. Braun Melsungen Description and Business Overview
6.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B. Braun Melsungen Drug Eluting Implant Product Portfolio
6.5.5 B. Braun Melsungen Recent Developments/Updates
6.6 MicroPort Scientific
6.6.1 MicroPort Scientific Company Information
6.6.2 MicroPort Scientific Description and Business Overview
6.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MicroPort Scientific Drug Eluting Implant Product Portfolio
6.6.5 MicroPort Scientific Recent Developments/Updates
6.7 Cook Medical
6.7.1 Cook Medical Company Information
6.7.2 Cook Medical Description and Business Overview
6.7.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cook Medical Drug Eluting Implant Product Portfolio
6.7.5 Cook Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Drug Eluting Implant Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Biosensors International
6.9.1 Biosensors International Company Information
6.9.2 Biosensors International Description and Business Overview
6.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Biosensors International Drug Eluting Implant Product Portfolio
6.9.5 Biosensors International Recent Developments/Updates
6.10 Balton
6.10.1 Balton Company Information
6.10.2 Balton Description and Business Overview
6.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Balton Drug Eluting Implant Product Portfolio
6.10.5 Balton Recent Developments/Updates
6.11 AlviMedica Medical Technologies
6.11.1 AlviMedica Medical Technologies Company Information
6.11.2 AlviMedica Medical Technologies Description and Business Overview
6.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolio
6.11.5 AlviMedica Medical Technologies Recent Developments/Updates
6.12 Biotronik
6.12.1 Biotronik Company Information
6.12.2 Biotronik Description and Business Overview
6.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Biotronik Drug Eluting Implant Product Portfolio
6.12.5 Biotronik Recent Developments/Updates
6.13 Shandong JW Medical
6.13.1 Shandong JW Medical Company Information
6.13.2 Shandong JW Medical Description and Business Overview
6.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shandong JW Medical Drug Eluting Implant Product Portfolio
6.13.5 Shandong JW Medical Recent Developments/Updates
6.14 Sino Medical
6.14.1 Sino Medical Company Information
6.14.2 Sino Medical Description and Business Overview
6.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sino Medical Drug Eluting Implant Product Portfolio
6.14.5 Sino Medical Recent Developments/Updates
6.15 Beijing AMSINO
6.15.1 Beijing AMSINO Company Information
6.15.2 Beijing AMSINO Description and Business Overview
6.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Beijing AMSINO Drug Eluting Implant Product Portfolio
6.15.5 Beijing AMSINO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Implant Industry Chain Analysis
7.2 Drug Eluting Implant Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Implant Production Mode & Process Analysis
7.4 Drug Eluting Implant Sales and Marketing
7.4.1 Drug Eluting Implant Sales Channels
7.4.2 Drug Eluting Implant Distributors
7.5 Drug Eluting Implant Customer Analysis
8 Drug Eluting Implant Market Dynamics
8.1 Drug Eluting Implant Industry Trends
8.2 Drug Eluting Implant Market Drivers
8.3 Drug Eluting Implant Market Challenges
8.4 Drug Eluting Implant Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boston Scientific
Medtronic Inc
Abbott
Lepu Medical
B. Braun Melsungen
MicroPort Scientific
Cook Medical
Terumo
Biosensors International
Balton
AlviMedica Medical Technologies
Biotronik AG
Shandong JW Medical
Sino Medical
Beijing AMSINO
List of Tables
 Table 1. Global Drug Eluting Implant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Eluting Implant Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Eluting Implant Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Eluting Implant Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Eluting Implant Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Eluting Implant Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Eluting Implant Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Eluting Implant Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Eluting Implant, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Eluting Implant, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Eluting Implant, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Eluting Implant, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Eluting Implant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Eluting Implant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Eluting Implant Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Eluting Implant Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Eluting Implant Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Eluting Implant Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Eluting Implant Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Eluting Implant Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Eluting Implant Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Eluting Implant Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Eluting Implant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Eluting Implant Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Eluting Implant Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Eluting Implant Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Eluting Implant Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Eluting Implant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Eluting Implant Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Eluting Implant Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Eluting Implant Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Eluting Implant Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Eluting Implant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Eluting Implant Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Eluting Implant Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Eluting Implant Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Eluting Implant Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Eluting Implant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Eluting Implant Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Eluting Implant Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Eluting Implant Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Eluting Implant Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Eluting Implant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Eluting Implant Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Eluting Implant Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Eluting Implant Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Eluting Implant Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Eluting Implant Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Eluting Implant Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Eluting Implant Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Eluting Implant Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Eluting Implant Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Eluting Implant Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Eluting Implant Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Eluting Implant Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Eluting Implant Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug Eluting Implant Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug Eluting Implant Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Eluting Implant Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Eluting Implant Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Eluting Implant Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Eluting Implant Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Eluting Implant Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Eluting Implant Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Eluting Implant Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Eluting Implant Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug Eluting Implant Price (US$/Unit) by Application (2026-2031)
 Table 70. Boston Scientific Company Information
 Table 71. Boston Scientific Description and Business Overview
 Table 72. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boston Scientific Drug Eluting Implant Product
 Table 74. Boston Scientific Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Drug Eluting Implant Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Drug Eluting Implant Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. Lepu Medical Company Information
 Table 86. Lepu Medical Description and Business Overview
 Table 87. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lepu Medical Drug Eluting Implant Product
 Table 89. Lepu Medical Recent Developments/Updates
 Table 90. B. Braun Melsungen Company Information
 Table 91. B. Braun Melsungen Description and Business Overview
 Table 92. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. B. Braun Melsungen Drug Eluting Implant Product
 Table 94. B. Braun Melsungen Recent Developments/Updates
 Table 95. MicroPort Scientific Company Information
 Table 96. MicroPort Scientific Description and Business Overview
 Table 97. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. MicroPort Scientific Drug Eluting Implant Product
 Table 99. MicroPort Scientific Recent Developments/Updates
 Table 100. Cook Medical Company Information
 Table 101. Cook Medical Description and Business Overview
 Table 102. Cook Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cook Medical Drug Eluting Implant Product
 Table 104. Cook Medical Recent Developments/Updates
 Table 105. Terumo Company Information
 Table 106. Terumo Description and Business Overview
 Table 107. Terumo Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Terumo Drug Eluting Implant Product
 Table 109. Terumo Recent Developments/Updates
 Table 110. Biosensors International Company Information
 Table 111. Biosensors International Description and Business Overview
 Table 112. Biosensors International Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Biosensors International Drug Eluting Implant Product
 Table 114. Biosensors International Recent Developments/Updates
 Table 115. Balton Company Information
 Table 116. Balton Description and Business Overview
 Table 117. Balton Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Balton Drug Eluting Implant Product
 Table 119. Balton Recent Developments/Updates
 Table 120. AlviMedica Medical Technologies Company Information
 Table 121. AlviMedica Medical Technologies Description and Business Overview
 Table 122. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. AlviMedica Medical Technologies Drug Eluting Implant Product
 Table 124. AlviMedica Medical Technologies Recent Developments/Updates
 Table 125. Biotronik Company Information
 Table 126. Biotronik Description and Business Overview
 Table 127. Biotronik Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Biotronik Drug Eluting Implant Product
 Table 129. Biotronik Recent Developments/Updates
 Table 130. Shandong JW Medical Company Information
 Table 131. Shandong JW Medical Description and Business Overview
 Table 132. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shandong JW Medical Drug Eluting Implant Product
 Table 134. Shandong JW Medical Recent Developments/Updates
 Table 135. Sino Medical Company Information
 Table 136. Sino Medical Description and Business Overview
 Table 137. Sino Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sino Medical Drug Eluting Implant Product
 Table 139. Sino Medical Recent Developments/Updates
 Table 140. Beijing AMSINO Company Information
 Table 141. Beijing AMSINO Description and Business Overview
 Table 142. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Beijing AMSINO Drug Eluting Implant Product
 Table 144. Beijing AMSINO Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Drug Eluting Implant Distributors List
 Table 148. Drug Eluting Implant Customers List
 Table 149. Drug Eluting Implant Market Trends
 Table 150. Drug Eluting Implant Market Drivers
 Table 151. Drug Eluting Implant Market Challenges
 Table 152. Drug Eluting Implant Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Implant
 Figure 2. Global Drug Eluting Implant Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Eluting Implant Market Share by Type: 2024 & 2031
 Figure 4. Rapamycin Eluting Implant Product Picture
 Figure 5. Paclitaxel Eluting Implant Product Picture
 Figure 6. Everolimus Eluting Implant Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Drug Eluting Implant Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Drug Eluting Implant Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Ambulatory Surgical Centers
 Figure 13. Others
 Figure 14. Global Drug Eluting Implant Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Drug Eluting Implant Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Drug Eluting Implant Sales (2020-2031) & (K Units)
 Figure 17. Global Drug Eluting Implant Average Price (US$/Unit) & (2020-2031)
 Figure 18. Drug Eluting Implant Report Years Considered
 Figure 19. Drug Eluting Implant Sales Share by Manufacturers in 2024
 Figure 20. Global Drug Eluting Implant Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Drug Eluting Implant Players: Market Share by Revenue in Drug Eluting Implant in 2024
 Figure 22. Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Drug Eluting Implant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Drug Eluting Implant Sales Market Share by Country (2020-2031)
 Figure 25. North America Drug Eluting Implant Revenue Market Share by Country (2020-2031)
 Figure 26. United States Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Drug Eluting Implant Sales Market Share by Country (2020-2031)
 Figure 29. Europe Drug Eluting Implant Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Drug Eluting Implant Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Drug Eluting Implant Revenue Market Share by Region (2020-2031)
 Figure 37. China Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Drug Eluting Implant Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Drug Eluting Implant Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Drug Eluting Implant Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Drug Eluting Implant Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Drug Eluting Implant Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Drug Eluting Implant by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Drug Eluting Implant by Type (2020-2031)
 Figure 58. Global Drug Eluting Implant Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Drug Eluting Implant by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Drug Eluting Implant by Application (2020-2031)
 Figure 61. Global Drug Eluting Implant Price (US$/Unit) by Application (2020-2031)
 Figure 62. Drug Eluting Implant Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Implantable Drug Eluting Devices Market Insights Forecast to 2030
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Implantable Coronary Drug Eluting Stent Market Research Report 2024
Cardiovascular Drug Eluting Stents DES Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Contraceptive Drug Eluting Devices Market Research Report 2024
Global Peripheral Intervention Drug Eluting Devices Market Insights Forecast to 2030
Global Biodegradable Drug Eluting Stents Market Research Report 2024
Medical Implants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Drug Eluting Sutures Market Research Report 2024
Global Contraceptive Drug Eluting Devices Market Research Report 2024
Global Biodegradable Polymer Drug eluting Stents BP DES Market Research Report 2024
Global Biodegradable Implantable Drug Delivery System Market Research Report 2024
Global Drug eluting Coronary Stents Market Research Report 2025
Global Bioresorbable Drug Eluting Stents Market Research Report 2025
Medical Implantable Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Eluting Peripheral Stents Market Research Report 2025
Drug Eluting Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronary Intervention Drug Eluting Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Soft Implantable Drug Delivery System Market Research Report 2024

RELATED REPORTS

Global Stem Cell Therapy for Multiple Sclerosis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35H13194
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30P9123
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Stem Cell Umbilical Cord Blood Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Othe-477
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Oncology Information System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9W6217
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions